- In May 2024, Leica Biosystems, a global leader in pathology workflow solutions, introduced the HistoCore PEGASUS Plus Tissue Processor, designed to optimize efficiency and reproducibility in histopathology laboratories. This next-generation system offers enhanced reagent management, energy efficiency, and real-time process monitoring, underscoring Leica’s commitment to precision diagnostics and workflow automation in tissue processing
- In April 2024, Thermo Fisher Scientific Inc. expanded its histology product line with the launch of PathStor XT, a compact tissue processing system aimed at improving turnaround time for small to mid-sized laboratories. By combining user-friendly design with smart process control, the innovation reinforces the company's strategy to deliver adaptable and scalable solutions across varying laboratory settings
- In March 2024, Sakura Finetek USA, Inc. unveiled its upgraded Tissue-Tek VIP 6 AI, featuring intelligent protocol optimization and remote connectivity. This release integrates AI-powered features to minimize operator intervention and ensure consistent tissue quality, demonstrating the company’s continued focus on automation and digitization in pathology workflows
- In February 2024, Milestone Medical Technologies, a key player in histopathology innovation, announced the global rollout of LOGOS One EVO, a hybrid tissue processor combining microwave and conventional technologies. This advanced system is aimed at reducing processing times without compromising specimen quality, reflecting Milestone's drive to modernize laboratory practices with energy-efficient, high-speed alternatives
- In January 2024, Epredia, a subsidiary of PHC Holdings Corporation, partnered with PathAI to enhance its automated tissue processing platforms with AI-enabled diagnostic support. The collaboration is focused on integrating digital tools into traditional histology systems, enabling better decision-making and standardization across labs. This initiative represents a significant step towards the convergence of tissue processing and digital pathology for improved clinical outcomes
